Renaissance Technologies’s Agios Pharmaceuticals AGIO Stock Holding History

Renaissance Technologies’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.8M	Buy	+505,600	New	+$17.7M	0.02%	802
2024 Q2	–	Sell	-14,714	Closed	-$430K	–	3453
2024 Q1	$430K	Sell	14,714 -28,000	-66%	-$750K	﹤0.01%	2920
2023 Q4	$951K	Buy	+42,714	New	+$957K	﹤0.01%	2440
2022 Q4	–	Sell	-31,000	Closed	-$877K	–	4085
2022 Q3	$877K	Sell	31,000 -31,000	-50%	-$832K	﹤0.01%	2574
2022 Q2	$1.38M	Buy	+62,000	New	+$1.4M	﹤0.01%	2484
2020 Q4	–	Sell	-74,800	Closed	-$2.62M	–	3350
2020 Q3	$2.62M	Buy	+74,800	New	+$3.28M	﹤0.01%	1972
2019 Q4	–	Sell	-121,000	Closed	-$3.92M	–	3478
2019 Q3	$3.92M	Buy	121,000 +70,700	+141%	+$2.93M	﹤0.01%	1934
2019 Q2	$2.51M	Buy	+50,300	New	+$2.69M	﹤0.01%	2219
2018 Q2	–	Sell	-69,100	Closed	-$5.65M	–	3232
2018 Q1	$5.65M	Buy	+69,100	New	+$5.34M	0.01%	1735
2014 Q4	–	Sell	-15,900	Closed	-$975K	–	2943
2014 Q3	$975K	Buy	+15,900	New	+$685K	﹤0.01%	2039

Other funds holding AGIO

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SCS Capital Management Boston, Massachusetts $11.2B AUM 12.39% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

Renaissance Technologies's AGIO Position: Q3 2026 in Review

Renaissance Technologies opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2026: 505,600 shares worth $16.8M. The stake represents 0.02% of the portfolio and ranks #802 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in AGIO as recently as Q1 2024.

Renaissance Technologies first reported a position in AGIO in Q3 2014 and has held it in 10 quarters since. 142 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

Renaissance Technologies held 505,600 shares of Agios Pharmaceuticals worth $16.8M as of Q3 2026.
Agios Pharmaceuticals was a new Renaissance Technologies position in Q3 2026.
Agios Pharmaceuticals made up 0.02% of Renaissance Technologies's portfolio in Q3 2026, its #802 holding.
Renaissance Technologies first reported a position in Agios Pharmaceuticals in Q3 2014 and has held it in 10 quarters since.
142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.